San Francisco, 19 March 2019: The Report Veterinary Pain Management Market Size, Share & Trends Analysis Report By Product
(NSAIDs, Anesthetics), By Indication, By Animal Type (Companion, Livestock), By
End Use, And Segment Forecasts, 2019 - 2026
The global veterinary pain management market size is expected to reach USD 1.73 billion by 2026,
according to a new report by Grand View Research, Inc. It is projected to
register a CAGR of 5.3% during the forecast period. Growing companion adoption
and incidence of veterinary diseases is expected to boost the growth. Moreover,
increasing income in the developing countries is another growth driver. For
instance, according to the American Veterinary Medical Association (AVMA) in
2017, around 46% household had multiple types of pets in U.S.
North America held the dominant share of
the veterinary pain management market in 2018, due to the favorable pet
insurance policies and strategic initiatives adopted by various companies
operating in the region. For instance, in August 2018, Zoetis Inc. acquired
Abaxis in a probe to expand its veterinary products portfolio.
Increasing number of veterinary
practitioners are anticipated to create growth opportunities in the market.
High prevalence of chronic diseases such as cancer, diabetes, and
osteoarthritis among others. These factors are projected to propel the market
in the forthcoming years.
Furthermore, key players are implementing
newer strategies such as product launch, merger and acquisitions, regional
expansions etc. for increasing their foothold in the market. For instance, in
March 2016, Dechra Pharmaceuticals acquired Putney in order to improve its
animal product portfolio. In October 2018, Boehringer Ingelheim invested USD 80
million for R&D pertinent to veterinary vaccines in France. Moreover,
increasing pet insurance coverage are further fueling the market growth.
Access Research Report of Veterinary Pain Management Market @ https://www.grandviewresearch.com/industry-analysis/veterinary-pain-management-market
Further key findings from the report suggest:
· NSAIDs accounted for the largest market
share in terms of revenue in 2018, owing to the increasing incidence of chronic
diseases
· Companion animal segment is expected to
exhibit lucrative growth over the forecast period owing to rise in pet adoption
and expenditure for better pet care
· Osteoarthritis (OA) segment is expected to
hold the largest market share in terms of revenue due to increasing incidence
of obesity which propels the risk for OA
· Post-operative pain segment is expected to
exhibit lucrative growth over the forecast period due to the increasing number
of surgeries for chronic disorders
· Asia Pacific is anticipated to witness
lucrative growth due to rise in pet adoption and expendable income, especially
in Japan and India
· Some of the key companies operating in the
veterinary pain management market are Zoetis, CEVA, Boehringer Ingelheim GmbH,
Bayer, Merck, and Elanco.
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the global veterinary pain management market on the basis of product,
indication, animal type, end use, and region:
Veterinary Pain Management Product Outlook
(Revenue, USD Million, 2014 - 2026)
·
NSAIDs
·
Anesthetics
·
Opioids
·
Others
Veterinary Pain Management Indication
Outlook (Revenue, USD Million, 2014 - 2026)
·
Osteoarthritis
·
Post-operative pain
·
Others
Veterinary Pain Management Animal Type
Outlook (Revenue, USD Million, 2014 – 2026
·
Livestock animal
·
Companion Animal
Veterinary Pain Management End Use Outlook
(Revenue, USD Million, 2014 - 2026)
·
Hospitals & Clinics
·
Others
Veterinary Pain Management Regional Outlook
(Revenue, USD Million, 2014 - 2026)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Veterinary Pain Management Market@ https://www.grandviewresearch.com/press-release/global-veterinary-pain-management-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
